The Effect of Acute Transcranial Bright Light on Anxiety Symptoms
NCT ID: NCT01938937
Last Updated: 2014-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-03-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Photobiomodulation in Anxiety Disorders
NCT07133893
Light Therapy for Chronic Insomnia in General Practice
NCT04612192
Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study
NCT03420456
Light Therapy in Disorders of Consciousness: Behavioral, Neuroimaging and (Neuro)Physiological Assessments.
NCT03174119
Bright Light: A Novel Treatment for Anxiety
NCT01064700
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcranial bright light exposure
Transcranially administered bright light exposure for 12 minutes
Transcranial bright light device
Transcranial sham exposure
Transcranially administered sham exposure for 12 minutes
Transcranial sham device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial bright light device
Transcranial sham device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The written informed consent is obtained from subject
* Subject's BAI total score \>= 7
Exclusion Criteria
* Subject abuses substance or has a dependence
* Subject has had suicidal idealization during the past month
* Subject use psychotropic medications
* Subject has unstable somatic disease
* Subject has used bright-light therapy for the current episode
* Subject is pregnant
* Subject is a relative of a member of research team
* Subject has used transcranial light treatment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Valkee Oy
INDUSTRY
University of Oulu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heidi Jurvelin
PhD student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oulu University
Oulu, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANX-a
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.